China SXT Pharmaceuticals, Inc. (SXTC) |
| 0.1 -0.042 (-29.73%) 01-13 16:00 |
| Open: | 0.137 |
| High: | 0.137 |
| Low: | 0.094 |
| Volume: | 32,617,562 |
| Market Cap: | 12(M) |
| PE Ratio: | -0.26 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Drug Manufacturers - Specialty & Generic |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 6.98 |
| Resistance 1: | 4.35 |
| Pivot price: | 1.30 |
| Support 1: | 0.09 |
| Support 2: | 0.08 |
| 52w High: | 6.98 |
| 52w Low: | 0.094 |
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China. The company offers advanced, fine, and regular TCMP products, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. As of March 31, 2022, it had an end-customer base of 68 pharmaceutical companies, 14 chain pharmacies, and 20 hospitals in 10 provinces and municipalities in China. The company was founded in 2005 and is headquartered in Taizhou, China.
| EPS | -8340000.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | -16.897 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | -1.00 |
| Return on Assets (ttm) | 11.7 |
| Return on Equity (ttm) | -18.3 |
Tue, 13 Jan 2026
China SXT Pharmaceuticals raises $10 million in registered offering - Investing.com
Tue, 13 Jan 2026
Univest Securities, LLC Announces Closing of $10 Million Registered Direct Offering for its Client China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) - The Manila Times
Fri, 09 Jan 2026
China SXT Pharmaceuticals to raise $10 million in share offering By Investing.com - Investing.com Nigeria
Fri, 09 Jan 2026
China SXT Pharmaceuticals Inc. Announces $10 Million Registered Direct Offering of Class A Ordinary Shares - Quiver Quantitative
Fri, 09 Jan 2026
China SXT Pharmaceuticals Inc. Announces $10 Million Registered Direct Offering - GlobeNewswire
Fri, 09 Jan 2026
Why one investor agreed to buy 66,666,666 shares of this drugmaker - Stock Titan
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |